#2936 on the rich list of 14,644 insiders
Phillip A. Sharp
Director at Alnylam Pharmaceuticals; Director at Vir Biotechnology. Based in Cambridge, Massachusetts.
$41.2M
in disclosed stock, −$142K (−0.34%) today
Live prices, last trade 2:58 PM ET
- Rank
- 2936th of 14,644
- Companies held
- 2
- Largest holding
- ALNY, 96.4% of total
- Latest SEC filing
- Jan 23, 2025
What the $41.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals ALNY Common Stock | Through Trust | 266,899 | $148.99 | $39.8M | 96.4% | Form 4, Jan 23, 2025 |
| Vir Biotechnology VIR Common Stock | Directly | 121,174 | $8.96 | $1.1M | 2.6% | Form 4, May 22, 2023 |
| Vir Biotechnology VIR Common Stock | Through Phillip A. Sharp Irrevocable Trust | 44,444 | $8.96 | $398K | 1.0% | Form 4, May 22, 2023 |
Share counts are the amounts Phillip A. Sharp reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2933 | Simon Kukes 10% owner, PEDEVCO. Houston, TX | $41.3M |
| 2934 | Bernd Greifeneder EVP, Chief Technology Officer, Dynatrace. Boston, MA | $41.3M |
| 2935 | Roger F. Rankin Insider, Hamilton Beach Brands Holding. Mayfield Heights, OH | $41.3M |
| 2936 | Phillip A. Sharp Director, Alnylam Pharmaceuticals. Cambridge, MA | $41.2M |
| 2937 | Richard N. Levy 10% owner, Dave. Chicago, IL | $41.2M |
| 2938 | Thad Jampol Chief Product Officer, Intapp. Palo Alto, CA | $41.2M |
| 2939 | Samuel Kintz PRESIDENT AND CEO, Enliven Therapeutics. Boulder, CO | $41.2M |
Other Alnylam Pharmaceuticals insiders
All ALNY insiders- John Maraganore$34.4MChief Executive Officer. #1986 overall
- Yvonne Greenstreet$12.7MChief Executive Officer. #7154 overall
- Jeffrey Poulton V.$9.2MEVP, Chief Financial Officer. #9351 overall
- Tolga Tanguler$5.1MEVP, Chief Commercial Officer. #14280 overall
- David E. I. Pyott$5.0MDirector. #9618 overall
- Akshay Vaishnaw$3.5MPresident. #3319 overall
Questions
How much stock does Phillip A. Sharp own?
Phillip A. Sharp holds $41,248,391 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 2936th on the Stock Rich List.
Is this Phillip A. Sharp's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.